LEE KLUTH: Open Payments
NPI 1992560049 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 78 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $827 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $200 |
| Amgen Inc. | 12 | $198 |
| Boston Scientific Corporation | 6 | $191 |
| Novartis Pharmaceuticals Corporation | 12 | $170 |
| Abbott Laboratories | 2 | $162 |
| Novo Nordisk Inc | 6 | $97 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $87 |
| Actelion Pharmaceuticals US, Inc. | 3 | $74 |
| ABIOMED | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
Products named: REPATHA, WATCHMAN FLX, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, LEQVIO, WAINUA, LifeVest, EVKEEZA, Wegovy.
Industry payments across MO — which companies pay providers there.
